No Data
No Data
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
Intra-Cellular Therapies' (NASDAQ:ITCI) Investors Will Be Pleased With Their Stellar 177% Return Over the Last Five Years
When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Turn A Profit?
S&P 500 Futures Drop In Premarket Trading; Intra-Cellular Therapies, Avantor Lag
Intra-Cellular Therapies Presents Data From The CAPLYTA Adjunctive MDD Phase 3 Program At The American College Of Neuropsychopharmacology Annual Meeting; Data Shows Robust Remission And Response Efficacy Rates In Patients Taking CAPLYTA, As Well As...
Intra-Cellular Therapies(ITCI.US) Officer Sells US$8.72 Million in Common Stock
$Intra-Cellular Therapies(ITCI.US)$ Officer Mates Sharon sold 102.7K shares of common stock on Dec 4, 5, 2024 at an average price of $84.9343 for a total value of $8.72 million.Source: Announcement